BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Qu J, Lu SH, Lu ZL, Xu P, Xiang DX, Qu Q. Pharmacogenetic and case-control study on potassium channel related gene variants and genetic generalized epilepsy. Medicine (Baltimore) 2017;96:e7321. [PMID: 28658141 DOI: 10.1097/MD.0000000000007321] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
Number Citing Articles
1 Gong JE, Liao HM, Long HY, Li XM, Long LL, Zhou L, Gu WP, Lu SH, Qu Q, Yang LM, Xiao B, Qu J. SCN1B and SCN2B gene variants analysis in dravet syndrome patients: Analysis of 22 cases. Medicine (Baltimore) 2019;98:e14974. [PMID: 30921204 DOI: 10.1097/MD.0000000000014974] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
2 Al-Eitan LN, Al-Dalalah IM, Elshammari AK, Khreisat WH, Almasri AY. The Impact of Potassium Channel Gene Polymorphisms on Antiepileptic Drug Responsiveness in Arab Patients with Epilepsy. J Pers Med 2018;8:E37. [PMID: 30441785 DOI: 10.3390/jpm8040037] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
3 Lu Q, Huang YT, Shu Y, Xu P, Xiang DX, Qu Q, Qu J. Effects of CYP3A5 and UGT2B7 variants on steady-state carbamazepine concentrations in Chinese epileptic patients. Medicine (Baltimore) 2018;97:e11662. [PMID: 30045320 DOI: 10.1097/MD.0000000000011662] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]